Business Combination - Narrative (Details) $ / shares in Units, $ in Thousands	Dec. 04, 2025 USD ($) $ / shares shares	Dec. 31, 2025 USD ($) $ / shares	Dec. 31, 2024 $ / shares
Business Acquisition [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Contingent consideration liability, current		$ 21,580
Contingent consideration liability, non-current		$ 96,780
Foresight Diagnostics, Inc.
Business Acquisition [Line Items]
Purchase consideration	$ 424,536
Issuance of common stock for acquisition (in shares) | shares	1,127,982
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Closing common stock price (in dollars per share) | $ / shares	$ 242.06
Shares to be issued for each share upon consideration transferred	0.028
Potential future milestone obligations	$ 175,000
Cash paid at closing to settle Foresight Diagnostics' debt	5,974
Foresight Diagnostics' transaction expenses settled by the Company	7,232
Contingent consideration liability	118,400
Contingent consideration liability, current	21,600
Contingent consideration liability, non-current	$ 96,800
Number of shares deposited In escrow account for purchase price adjustments | shares	9,505
Estimated fair value of the adjustment escrow shares	$ 2,300
Stockholder representative allocable expenses	$ 1,000
Foresight Diagnostics, Inc. | Developed technology
Business Acquisition [Line Items]
Discount rate used to determine fair value	12.00%
Foresight Diagnostics, Inc. | Additional Paid-in Capital
Business Acquisition [Line Items]
Acquisition related costs	$ 100
Foresight Diagnostics, Inc. | Selling, general and administrative
Business Acquisition [Line Items]
Acquisition related costs	$ 3,900